April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Edaravone, A Ros Scavenger, Ameliorates Photoreceptor Apoptosis After Experimental Retinal Detachment
Author Affiliations & Notes
  • Miin Roh
    Ophthalmology, MEEI, Angiogenesis Lab, Boston, Massachusetts
  • Yusuke Murakami
    Ophthalmology, MEEI, Angiogenesis Lab, Boston, Massachusetts
  • Aristomenis Thanos
    Ophthalmology, MEEI, Angiogenesis Lab, Boston, Massachusetts
  • Demetrios Vavvas
    Ophthalmology, MEEI, Angiogenesis Lab, Boston, Massachusetts
  • Joan W. Miller
    Ophthalmology, MEEI, Angiogenesis Lab, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Miin Roh, None; Yusuke Murakami, None; Aristomenis Thanos, None; Demetrios Vavvas, None; Joan W. Miller, None
  • Footnotes
    Support  the Neovascular Research Fund (JM, MR), the Bacardi Fund (DV), the Research to Prevent Blindness Foundation (DV), the Lions Eye Research Fund (DV), the Onassis Foundation (DV), a Fight For Sight Grant
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4914. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Miin Roh, Yusuke Murakami, Aristomenis Thanos, Demetrios Vavvas, Joan W. Miller; Edaravone, A Ros Scavenger, Ameliorates Photoreceptor Apoptosis After Experimental Retinal Detachment. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4914.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate whether edaravone (3-methyl1-phenyl-2-pyrazolin-5-one), a free radical scavenger is neuroprotective against photereceptor death in a rat model of retinal detachment (RD).

Methods: : RD was induced in adult Brown Norway rats by subretinal injection of sodium hyaluronate. Edaravone (3 mg/kg, 5 mg/kg, 10 mg/kg) or physiologic saline were administered intraperitoneally once a day until sacrifice on day 3 or 5. Oxidative stress in the retina was assessed by 4-hydroxynonenal staining or ELISA for protein carbonyl content. Photoreceptor death was assessed by TUNEL and measurement of the outer nuclear layer thickness . Western blot analysis and caspase activity assays were performed. Inflammatory cytokine secretion and inflammatory cell infiltration were evaluated by ELISA and immunostaining, respectively.

Results: : RD resulted in increased generation of ROS. Treatment with 5 mg/kg edaravone significantly reduced ROS level along with decrease in TUNEL positive cells in the photoreceptor layer. Caspase assay also confirmed decreased activation of caspases -3,-,8, and -9 in RD treated with edaravone. The level of the anti-apoptotic Bcl-2 was increased in detached retinas after edaravone treatment, whereas the levels of the stress-activated p-ERK1/2 were decreased. Additionally, edaravone treatment resulted in a significant decrease in the levels of TNF-α, MCP-1 and macrophage infiltration.

Conclusions: : Oxidative stress plays an important role in the photoreceptor apoptosis after RD. Edaravone treatment may aid in preventing photoreceptor apoptosis following RD by suppressing ROS-induced photoreceptor damage.

Keywords: retinal detachment • oxidation/oxidative or free radical damage • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×